Browsing: immunotherapy

The FDA granted accelerated approval for Voceryq, the first plasmid DNA-based immunotherapy for adults with recurrent respiratory papillomatosis, a rare condition caused by HPV.

Merck presented trial data for its mRNA melanoma vaccine showing reduced recurrence and death when combined with an immunotherapy drug.

Researchers at WEHI identified gamma delta T cells that detect and destroy small cell lung cancer, suggesting a new approach to lung cancer treatment.

Patients with high-risk bowel cancer remained free of recurrence for nearly three years after receiving immunotherapy before surgery, according to the NEOPRISM-CRC trial.